Imperagen raises £5 million to make use of quantum physics, AI on enzyme engineering
Biotech firm Imperagen announced on Thursday a £5 million ($6.7 million) seed spherical led by PXN Ventures, with participation from IQ Capital and Northern Gritstone. The corporate was based in 2021 by Manchester Institute of Biotechnology scientists Dr. Andrew Currin, Dr. Tim Eyes, and Dr. Andy Almond and spun out of the college. The startup…